EDGAR Filing Documents for 0001193125-23-278858

Form 8-K - Current report:

SEC Accession No. 0001193125-23-278858

Filing Date

2023-11-16

Accepted

2023-11-16 16:35:57

Documents

Period of Report

2023-11-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d881994d8k.htm iXBRL	8-K	76692
2	EX-2.1	d881994dex21.htm	EX-2.1	432014
3	EX-10.1	d881994dex101.htm	EX-10.1	21187
4	EX-10.2	d881994dex102.htm	EX-10.2	28478
5	EX-10.3	d881994dex103.htm	EX-10.3	19350
6	EX-10.4	d881994dex104.htm	EX-10.4	33927
7	EX-99.1	d881994dex991.htm	EX-99.1	17355
	Complete submission text file	0001193125-23-278858.txt		962806

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	blacw-20231113.xsd	EX-101.SCH	4238
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	blacw-20231113_def.xml	EX-101.DEF	15008
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	blacw-20231113_lab.xml	EX-101.LAB	25999
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	blacw-20231113_pre.xml	EX-101.PRE	15961
13	EXTRACTED XBRL INSTANCE DOCUMENT	d881994d8k_htm.xml	XML	8753

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004

Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700

Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)